SpaceX's stock fell below its $135 IPO price following a Starship launch delay, but the article argues the delay itself is unlikely to materially impact the company's long-term investment thesis. The stock decline is attributed more to thin trading float (only 4% of shares trade publicly), AI sector sell-offs, and pending lock-up expirations rather than the business fundamentals. Near-term revenue drivers like Starlink and AI compute deals remain unaffected by the delay.

SpaceX has fallen back to its IPO price of $135. The article compares two alternatives: AST SpaceMobile, which focuses on satellite-based broadband through telecom partnerships but doesn't launch its own satellites, and Rocket Lab, which will become fully integrated after acquiring Iridium Communications. All three companies are unprofitable startups, making them suitable only for aggressive growth investors.

Rocket Lab generates approximately $200 million in quarterly revenue with 60% year-over-year growth and a $2 billion backlog, while AST SpaceMobile expects only $150-200 million for all of 2026. Rocket Lab represents a lower-risk, established business with proven revenue streams, whereas AST SpaceMobile is transitioning from development to commercial service with higher upside potential if its satellite-to-phone technology scales successfully.

The article compares SpaceX and Rocket Lab as space investment opportunities. While SpaceX pursues ambitious goals including Mars colonization, AI platforms, and Starlink expansion, it faces mounting losses ($3.29 per share in Q1) and massive capital expenditures ($10 billion in Q1 alone). Rocket Lab, though unprofitable, shows stronger momentum with 64% revenue growth, 31 new launch contracts signed in Q1, and improving losses. The article concludes Rocket Lab is the better buy due to its lower valuation (P/S ratio of 66 vs. SpaceX's 94) and stronger operational trajectory.

Rocket Lab has been selected to compete for the Space Force's $5.6 billion National Security Space Launch (NSSL) Phase 3 program through 2029. However, the company cannot win any contracts until its Neutron reusable medium-lift rocket completes a successful first flight, currently targeted for Q4 2026. Success depends entirely on Neutron's execution, as the company faces competition from established providers like SpaceX and United Launch Alliance.

SpaceX stock has declined 7% since its June IPO debut and trades at an inflated valuation of nearly $2 trillion with a price-to-sales ratio of ~100x. The company posted net losses despite $18.7 billion in 2025 revenue and raised $25 billion in bonds. While SpaceX has strong long-term potential through its rocket launch business and Starlink, the analyst predicts the stock will fall to around $100 per share by year-end due to insider selling and execution risks, with limited upside at current valuations.

Rocket Lab stock surged 46% in the first half of 2026, outperforming the S&P 500's 10% gain. The company delivered record-breaking quarterly results with 36-63% year-over-year revenue growth, a $2.2 billion backlog (up 106% YoY), and 70 contracted missions. The $8 billion Iridium acquisition positions it as an end-to-end space company. Wall Street analysts are bullish with 81% buy/strong buy ratings and an average price target of $117, suggesting 61% upside potential.

Three major company CEOs recently sold significant amounts of stock. Casey's General Stores CEO sold $15.2M in shares after strong 200% gains since 2024, suggesting portfolio diversification. Rocket Lab CEO sold $286M but retains massive holdings, indicating wealth management rather than concern. RH CEO sold $21M despite poor performance, but the sale represents only a 4% reduction in holdings, with another insider buying shares—a potentially bullish signal.

SpaceX and Rocket Lab are the two purest public examples of vertically integrated space companies, controlling their own rockets, satellites, and services. SpaceX is the dominant leader with proven scale and integration, while Rocket Lab is earlier in executing the same playbook through recent acquisitions like Iridium. SpaceX is the safer choice for established dominance, but Rocket Lab offers higher growth potential at a cheaper valuation for risk-tolerant investors.

Rocket Lab has developed the 'Hungry Hippo,' an innovative hinged fairing design for its upcoming Neutron rocket that remains attached to the first stage during launch and recovery, potentially reducing costs and improving payload capacity. However, the technology remains unproven as Neutron's first launch has been delayed to late 2026, and the company continues to operate unprofitably.

The article compares two aerospace and defense ETFs: Invesco Aerospace & Defense ETF (PPA), a passively managed fund focused on traditional defense contractors with lower costs and higher long-term returns, and ARK Space & Defense Innovation ETF (ARKX), an actively managed fund with higher volatility that concentrates on space technology innovation. While PPA offers stability and lower fees, ARKX has delivered stronger recent returns, making the choice dependent on investor risk tolerance and confidence in active management.

Rocket Lab has surged 118% over the past year and is positioning itself as a major player in the space industry. The company achieved record launch contracts (31 in Q1 2026) and announced an $8 billion acquisition of Iridium Communications to expand into satellite communications. While the company shows strong growth metrics and government contracts, investors should be aware of its lack of profitability, high valuation (P/S ratio of 82), and stock volatility.